Skip to content
Clinical Trials – home

Sumatriptan Succinate: A Comprehensive Guide for Patients

0 / 2
trials open to patients / all trials
1+
Countries

In short

Sumatriptan Succinate, a medication used to treat migraines and cluster headaches, has been the subject of several clinical trials. These studies aim to evaluate its effectiveness, safety, and various delivery methods. The trials compare different formulations of Sumatriptan Succinate, including oral tablets, injections, nasal sprays, and innovative delivery systems like transdermal patches. Researchers are exploring how these different forms of the medication affect its absorption, distribution, and overall effectiveness in treating migraine symptoms.

At a glance

Study Types
Pharmacokinetic studies, bioequivalence studies, safety and efficacy trials
Formulations Studied
Oral tablets, subcutaneous injections, nasal sprays, transdermal patches, iontophoretic systems
Key Measures
Cmax (maximum concentration), AUC (area under the curve), Tmax (time to maximum concentration)
Comparison Products
Imitrex (brand name for sumatriptan), TREXIMA (combination of sumatriptan and naproxen)
Novel Delivery Systems
Sofusa system, NP101 iontophoretic transdermal patch
Study Designs
Crossover studies, open-label trials, randomized controlled trials
Patient Populations
Healthy volunteers, migraine patients, cluster headache patients
Safety Assessments
Adverse events, vital signs, ECGs, clinical laboratory tests

What is Sumatriptan Succinate?

Sumatriptan Succinate is a medication primarily used for the treatment of migraine headaches. It belongs to a class of drugs known as triptans, which are specifically designed to alleviate migraine symptoms. Sumatriptan is also known by its brand name Imitrex.

What Conditions Does Sumatriptan Treat?

Sumatriptan is primarily used to treat:

  • Migraine headaches: This includes migraines with or without aura. An aura is a sensory disturbance that some people experience before a migraine attack, such as seeing flashing lights or experiencing numbness.
  • Cluster headaches: These are extremely painful headaches that occur in cyclical patterns or clusters.

How is Sumatriptan Administered?

Sumatriptan can be administered in several ways:

  • Oral tablets: Available in various strengths, including 100mg tablets.
  • Subcutaneous injection: This is an injection given just under the skin, often using a device called the IMITREX STATdose System. It's available in 4mg and 6mg doses.
  • Nasal spray: This formulation is sprayed into the nostril.
  • Transdermal patch: This is a newer method of administration where the medication is delivered through the skin. It's still under research and development.

How Does Sumatriptan Work?

Sumatriptan works by:

  • Narrowing blood vessels in the brain, which can become dilated during a migraine attack.
  • Blocking the release of certain chemicals in the brain that cause pain and other migraine symptoms.
  • Reducing inflammation in the brain that contributes to migraine pain.

Effectiveness of Sumatriptan

Clinical trials have shown that Sumatriptan is effective in treating migraine headaches. Some key findings include:

  • Many patients experience headache relief within 2 hours of taking the medication.
  • Sumatriptan can also help alleviate other migraine symptoms such as nausea, photophobia (sensitivity to light), and phonophobia (sensitivity to sound).
  • The effectiveness can vary depending on the method of administration and the individual patient.

Potential Side Effects

Like all medications, Sumatriptan can cause side effects. Common side effects may include:

  • Tingling or warm sensations
  • Dizziness
  • Fatigue
  • Chest discomfort
  • Injection site reactions (for the injectable form)
  • Nasal discomfort (for the nasal spray form)

It's important to discuss potential side effects with your healthcare provider before starting treatment.

Ongoing Research and Development

Researchers continue to study Sumatriptan to improve its effectiveness and delivery methods. Some areas of ongoing research include:

  • Combination therapies: For example, a combination of Sumatriptan and Naproxen Sodium (known as Trexima) is being studied for potential improved efficacy.
  • New delivery methods: Such as the Sofusa system, which is a transdermal delivery system designed to administer Sumatriptan through the skin.
  • Improved formulations: Researchers are working on developing formulations that may provide faster relief or have fewer side effects.

Questions people often ask

Conditions where Sumatriptan Succinate is being studied

Each condition opens its own overview and trial list

Trials with Sumatriptan Succinate

Recruiting trials first

See all 2 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).